On September 2, 2026, the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”), the Board of Governors of the Federal Reserve System (“Federal Reserve”), the Federal Deposit Insurance Corporation (“FDIC”), the National Credit Union Administration (“NCUA”), and the
McGuireWoods LLP
McGuireWoods, one of the world’s leading law firms, has earned the loyalty of its many longstanding clients with deep and broad legal experience; a passion for understanding their businesses and markets; innovative delivery of practical, business-minded solutions; and unmatched service. With 1,100 lawyers in 21 offices worldwide, McGuireWoods’ continuing success comes down to one simple fact: The firm listens to its clients.
Latest from McGuireWoods LLP - Page 2
Healthcare & Life Sciences Private Equity Deal Tracker: Nordic to Acquire BWXT’s Medical Business
Nordic Capital has entered into a definitive agreement to acquire the medical business of BWX Technologies in a transaction valued at up to $800 million, according to a news release.
BWX Technologies (NYSE: BWXT), based in Lynchburg, Virginia, is…
Deal Activity, AI and Regulatory Pressure with Holly Buckley
In this episode of the Becker Private Equity & Business Podcast, Holly Buckley, Chair of Healthcare at McGuireWoods, discusses the latest healthcare private equity trends, including transaction volume, physician practice investments, AI adoption, state regulations and the outlook for…
Prescribed Pediatric Care at Scale, With Jeff Soffen
Three million children in the U.S. could benefit from Prescribed Pediatric Extended Care (PPEC), but most families don’t know it exists. Jeffrey Soffen, CEO of Spark Pediatrics, the largest PPEC provider in the country, joins McGuireWoods partner Tim…
Healthcare & Life Sciences Private Equity Deal Tracker: RS2 Invests in KMM Group
RS2 Healthcare Partners has invested in KMM Group, according to a news release.
KMM, founded in 2020 and based in Hatboro, Pennsylvania, is a contract manufacturer specializing in components for the medical device industry and other markets.
RS2…
Healthcare & Life Sciences Private Equity Deal Tracker: SkyKnight to Invest in Apex Infusion
SkyKnight Capital has entered into a definitive agreement to invest in Apex Infusion, according to a news release.
Apex, founded in 2006 and headquartered in Signal Hill, California, is an infusion provider that delivers therapies to patients across…
California’s SB 690: Legislative Relief on the Horizon for Website Privacy Claims
California Senate Bill 690 (“SB 690”) continues to advance in the California state legislature. SB 690 seeks to limit litigation brought pursuant to the California Invasion of Privacy Act (“CIPA”) given the avalanche of website technology litigation, which continues unabashedly.…
Healthcare & Life Sciences Private Equity Deal Tracker: Warburg Pincus-Led Investor Group to Acquire PANTHERx Rare
Warburg Pincus has announced that a Warburg Pincus-led investor group has agreed to acquire a controlling interest in PANTHERx Rare from Nautic Partners, General Atlantic and The Vistria Group, supported by a material minority investment from a subsidiary of the…
Department of War Launches Research Security Audits: Key Compliance Steps for Higher Education Institutions
Background
On August 17, 2026, the Department of War issued formal notifications to 30 domestic academic institutions directing them to initiate immediate and comprehensive reviews of their academic, financial, and research collaborations with foreign entities of concern. The notifications were…
SkyKnight Closes New Fund at $2 Billion
SkyKnight Capital has announced the close of its fifth fund.
The fund — SkyKnight Capital Fund V — closed with $2 billion in commitments.
SkyKnight Capital, founded in 2015 and with locations in Burlingame, California and New York, is…